Opthea Limited Sponsored ADR (OPT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Opthea Limited, a biopharmaceutical company focused on innovative treatments for retinal diseases, will engage with investors at the Citi 2024 Global Healthcare Conference. CEO Fred Guerard will lead discussions on Opthea’s advancements, highlighting their Phase 3 trials aimed at enhancing treatment efficacy for conditions like wet age-related macular degeneration.
For further insights into OPT stock, check out TipRanks’ Stock Analysis page.
